Trials / Conditions / Primary Amyloidosis
Primary Amyloidosis
5 registered clinical trials studyying Primary Amyloidosis.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Minimal Residual Disease as a Possible Predictive Factor for Relapse in Patients With AL Amyloidosis NCT02555969 | Tufts Medical Center | — |
| Completed | Phase 1/2, Open Label, Dose Escalation Study of NEOD001 in Subjects With Light Chain (AL) Amyloidosis NCT01707264 | Prothena Biosciences Ltd. | Phase 1 / Phase 2 |
| Completed | A Trial of Treatment With Lenalidomide-Melphalan-Dexamethasone in Patients With Primary (AL) Amyloidosis NCT00883623 | Heidelberg University | Phase 2 |
| Completed | Radioimmunoimaging of AL Amyloidosis NCT00807872 | University of Tennessee | Phase 1 |
| Completed | Trial of Two Stem Cell Doses To Reduce Transplant Induced Symptom Burden NCT00651937 | M.D. Anderson Cancer Center | Phase 2 |